PRESS RELEASE published on 06/23/2025 at 08:03, 5 months 12 days ago AB Science - De nouvelles données évaluées par des pairs apportent des preuves solides du potentiel du masitinib dans le traitement de la maladie d’Alzheimer Des données évaluées par des pairs confirment l'efficacité potentielle du masitinib dans le traitement de la maladie d'Alzheimer, avec un focus sur l'amélioration cognitive et la neuroprotection Traitement Maladie D'Alzheimer Étude Clinique Cognition Masitinib
PRESS RELEASE published on 06/23/2025 at 08:03, 5 months 12 days ago AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease New peer-reviewed data supports masitinib's potential for treating Alzheimer's disease through cognitive enhancement and neuroprotection. Phase 3 study authorized by FDA and key EU countries Alzheimer's Disease Phase 3 Study Neuroprotection Masitinib Cognitive Enhancement
BRIEF published on 06/09/2025 at 08:05, 5 months 26 days ago EMA Approves Extended Shelf-Life for MASIVET® by AB Science Veterinary Medicine AB Science EMA Approval MASIVET® Shelf-life Extension
BRIEF published on 06/09/2025 at 08:05, 5 months 26 days ago L'EMA approuve la prolongation de la durée de conservation de MASIVET® d'AB Science Médecine Vétérinaire AB Science Approbation De L'EMA MASIVET® Prolongation De La Durée De Conservation
PRESS RELEASE published on 06/09/2025 at 08:00, 5 months 26 days ago AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans AB Science annonce l'approbation par l'EMA de la prolongation de la durée de conservation de Masivet à 4 ans, offrant une plus grande flexibilité et continuant à assurer les traitements actuels et futurs Traitement AB Science EMA MASIVET Durée De Conservation
PRESS RELEASE published on 06/09/2025 at 08:00, 5 months 26 days ago AB Science announces EMA approval of Masivet shelf-life extension to 4 years AB Science receives EMA approval for 4-year shelf-life extension of MASIVET(R) veterinary medicine, providing enhanced flexibility for patients and caregivers Veterinary Medicine AB Science EMA Approval Shelf-life Extension MASIVET
BRIEF published on 05/23/2025 at 07:57, 6 months 13 days ago AB Science renforce sa trésorerie avec une augmentation de capital Euronext Paris Financement Augmentation De Capital Investisseurs AB Science
BRIEF published on 05/23/2025 at 07:57, 6 months 13 days ago AB Science strengthens its cash flow with a capital increase Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE published on 05/23/2025 at 07:52, 6 months 13 days ago AB Science announces the settlement delivery of its latest capital increase for €1.8 million AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases Healthcare Industry Financial News Capital Increase Drug Development AB Science
PRESS RELEASE published on 05/23/2025 at 07:52, 6 months 13 days ago AB Science : AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse Augmentation De Capital Trésorerie AB Science Masitinib AB8939
Published on 12/05/2025 at 17:00, 10 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 35 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 17:00, 10 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 45 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 12 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry